Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
RE ›
REZFORZIN
Trademark search for:
REZFORZIN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-11-09 — Application filed
2020-11-12 — Application filed
2021-01-07 — Application filed
2021-04-16 — Assigned to examiner
2021-04-19 — Final disposition recorded
2021-04-19 — Final disposition recorded
2021-04-19 — Final disposition recorded
2021-10-19 — Teas/email correspondence entered
2021-10-19 — Office action issued
2021-10-19 — Correspondence received in law office
2021-10-20 — Approved for pub - principal register
2021-11-03 — Notification of notice of publication e-mailed
2021-11-23 — Published for opposition
2021-11-23 — Official gazette publication confirmation e-mailed
2022-01-18 — Noa e-mailed - sou required from applicant
2022-07-13 — Sou teas extension received
2022-07-13 — Sou extension 1 filed
2022-07-13 — Sou extension 1 granted
2022-07-15 — Notice of approval of extension request e-mailed
2023-01-17 — Sou teas extension received
2023-01-17 — Sou extension 2 filed
2023-01-17 — Sou extension 2 granted
2023-01-19 — Notice of approval of extension request e-mailed
2023-08-21 — Application abandoned
2023-08-21 — Application abandoned
2023-08-21 — Final status recorded
Owner Information
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc.
Correspondent
Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
